Mitochondria and vascular calcification in chronic kidney disease: Lessons learned from the past to improve future...

Area of Science:

• Nephrology
• Cardiovascular Science
• Mitochondrial Biology

Background:

• Chronic kidney disease-mineral and bone disorders (CKD-MBD) is a frequent complication in CKD Stages 3-5.
• Hyperphosphatemia in CKD-MBD contributes to vascular calcification (VC), increasing cardiovascular risk, especially with long-term renal replacement therapy.
• Vascular smooth muscle cell osteochondrogenic transformation and apoptosis are key processes in VC development.

Purpose of the Study:

• To review experimental and clinical studies on mitochondria in CKD-MBD and vascular calcification.
• To discuss interventions targeting mitochondrial function, dynamics, and oxidative stress for attenuating VC.
• To explore strategies for improving outcomes in CKD patients with VC.

Main Methods:

• Comprehensive literature review of experimental and clinical reports.
• Focus on studies investigating mitochondrial dysfunction and oxidative stress in CKD-MBD and VC.
• Analysis of interventions targeting mitochondrial pathways.

Main Results:

• Mitochondrial dysfunction and oxidative stress are implicated in CKD progression and VC.
• Vascular smooth muscle cells undergo detrimental changes due to these factors.
• Emerging interventions focus on improving mitochondrial health to combat VC.

Conclusions:

• Mitochondrial dysfunction is a critical factor in the pathogenesis of vascular calcification in CKD-MBD.
• Targeting mitochondrial function and reducing oxidative stress holds promise for novel therapeutic strategies.
• Further research into mitochondrial interventions is crucial for improving cardiovascular outcomes in CKD patients.